Hummsa Biotech
1 known investors
Hummsa Biotech develops oral small molecule therapeutics targeting chronic metabolic diseases through multi-targeted approaches, aiming to shift treatment from reactive to preventive and regenerative care. The company prioritizes affordability and accessibility across global markets.
Founders & leadership
TM
Timo Müller
Investors · 1
Frequently asked questions
- What does Hummsa Biotech do?
- Hummsa Biotech develops oral small molecule therapeutics targeting chronic metabolic diseases through multi-targeted approaches, aiming to shift treatment from reactive to preventive and regenerative care. The company prioritizes affordability and accessibility across global markets.
- Who are Hummsa Biotech's investors?
- Hummsa Biotech's investors include Randev Ventures Family Office.